InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the full record of transactions filed by Shin Nippon Biomedical Laboratories, Ltd.. Director active across 1 company, notably Satsuma Pharmaceuticals, Inc.. Aggregated, 1 filings have been recorded. Split: 1 buy · 0 sell. Total volume traded: €18.8m. Activity tracked since 6 June 2023. The latest transaction was filed on 6 June 2023 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
1 of 1 declaration